Rehabilitation Systems in Massachusetts

SwimEx, Inc. is a Massachusetts-based manufacturer of custom-designed aquatic therapy and rehabilitation pools founded in 1986. The company specializes in resistance pools featuring patented paddlewheel water current technology for therapeutic and athletic training applications. SwimEx serves hospitals, rehabilitation clinics, senior living facilities, veterinary practices, athletic teams, sports institutions, spas, wellness centers, and residential customers worldwide. Their commercial-grade fiberglass pools are engineered for durability and low maintenance, offering adjustable water flow for full-body fitness, injury recovery, balance improvement, and neurological rehabilitation. The company's DepthSelect™ Series provides adjustable treadmill zone depth to support staged rehabilitation protocols. SwimEx pools are trusted by professional sports teams (Philadelphia Eagles, New England Patriots, Utah Jazz), universities, and healthcare institutions for both performance training and therapeutic recovery programs.

XRHealth is a digital health company specializing in AI-powered extended reality (XR) therapeutic solutions for clinical and home-based care. The company develops virtual reality and immersive software platforms that deliver evidence-based treatment for pain management, cognitive behavioral therapy, physical rehabilitation, occupational therapy, and mental health interventions. XRHealth's flagship product, the XRHealth VR CBT Device, is Medicare-covered as durable medical equipment (DME) under HCPCS Code E1905. The company also offers the XR CareCart, a plug-and-play VR rehabilitation station for deployment in clinics, hospitals, and community settings. XRHealth 2.0 is described as a unified XR therapeutic ecosystem integrating AI-driven personalization, dynamic avatars, and clinical support tools. The platform supports conditions including anxiety, ADHD, autism spectrum disorder, Parkinson's disease, stroke rehabilitation, cancer-related symptoms, and burn wound management. XRHealth holds FDA registration for its medical devices and has secured patents for XR-based impulsivity measurement systems. The company operates through multiple acquisition-driven product lines (acquired Innerworld, RealizedCare, NeuroReality/Koji's Quest, and merged with Amelia Virtual Care) and positions itself as a B2B provider serving healthcare organizations, clinicians, therapists, and patients. Services include clinical delivery, treatment planning, and clinician AI assistant functionality.

Computer Sports Medicine, Inc. (CSMi) is a family-owned manufacturer of computer-based measurement, training, and documentation solutions for athletic training, exercise science, and physical therapy. Founded in 1982 and based in Stoughton, Massachusetts, CSMi serves hospitals, clinics, research centers, training rooms, industrial sites, and educational institutions across 30+ countries. The company's flagship product, HUMAC NORM, is a gold-standard isokinetic testing and rehabilitation system offering four resistance modes and 22 isolated-joint patterns for objective strength assessment and functional rehabilitation across shoulder, elbow, wrist, hip, knee, and ankle. CSMi also provides SportsWareOnLine, a HIPAA- and FERPA-compliant web-based electronic medical record (EMR) platform purpose-built for athletic trainers to document injuries, treatments, and return-to-play decisions, already managing records for over four million athletes worldwide. The company's integrated solutions enable clinicians, researchers, and athletic professionals to collect objective data, track recovery outcomes with confidence, and support evidence-based rehabilitation protocols.

ONWARD Medical is a clinical-stage medical device company developing non-invasive spinal cord stimulation therapies for people with spinal cord injury (SCI). The company's primary commercial product is the ARCEX System, a transcutaneous electrical spinal cord stimulation device FDA-cleared and CE-marked for improving hand sensation and strength in individuals with chronic cervical spinal cord injury (C2-C8). The ARCEX System comprises a wearable stimulator that delivers programmed electrical pulses via electrodes placed on the skin at the back of the neck, designed for use in conjunction with functional task practice in clinical rehabilitation settings and home-based exercise programs. The company has received 10 FDA Breakthrough Device Designations and holds nearly 400 issued or pending patents. Clinical evidence from the Up-LIFT study, published in Nature Medicine, demonstrated that 90% of 65 participants improved upper limb strength or function, with 87% reporting improved quality of life. ONWARD is also developing investigational therapies including ARCIM (implantable spinal cord stimulation) and ARCBCI (brain-computer interface combined systems), neither yet commercially available. The company collaborates with leading SCI research centers and rehabilitation organizations globally. Manufacturing and clinical delivery capabilities support both clinic-based and at-home patient use.